• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Catalog Number CLXECP
Device Problem Leak/Splash (1354)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/04/2022
Event Type  malfunction  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the reportable malfunction tubing leak.Since this reportable malfunction is only associated with the kit, this mdr will only be against the kit.A batch record review for kit lot k257 was conducted.There were no non-conformances associated with this lot.A review of kit lot k257 identified an increase in complaints for this kit lot.This assessment is based on the information available at the time of the investigation.At the time of this report, the complaint kit has not yet been received.A supplemental report will be filed when the analysis is complete.(b)(4).
 
Event Description
The customer contacted mallinckrodt to report they experienced a tubing leak with their cellex photopheresis kit ("kit") during an extracorporeal photopheresis (ecp) treatment.The customer reported the leak was coming from the saline tubing.The customer reported the ecp treatment was completed and blood was returned to the patient.The customer reported the patient was in stable condition.The customer provided a photograph and will return the kit for investigation.
 
Manufacturer Narrative
Review of the provided photograph verifies the reported tubing leak as there is a cut in the tubing leading up to the saline drip chamber.Capa-2022-0120 was initiated to investigate the increase in tubing leak complaints observed for kit lot k257.The tubing leak occurred at the saline spike chamber and tubing bond interface.A review of the 50/50 solvent used to adhere the saline spike to the clear tubing was performed.A material trace of the spike chamber, clear tubing and 50/50 solvent used to build lot k257 did not find any non-conformances.The solvent used to adhere the saline spike and clear tubing is also used for other bonds.All other bonds on the returned samples were reviewed and inspected.No issues were observed with the other bonds.Three retains from kit lot k257 were pressure tested to check for leaks and no leaks were observed.During incoming inspection spike chambers and clear tubing are sampled and inspected for any obvious damage.The inner diameter of the port at the base of the spike chamber is measured along with the length of the spikes at the top of the spike chamber to ensure they are within specification.Clear tubing is inspected, and a sample of the tubing outer and inner diameter are measured to verify they are within specification.No issues were found at incoming inspection of the spike chambers and clear tubing.Manufacturing bonding operators follow work instruction operation 60a step 7 to bond the clear tubing to the spike chamber using a 50/50 double solvent dip.Operators are to hold the bond for approximately 5 seconds to ensure the tubing does not push back out of the bond socket.The tubing leak from the bond port indicates the solvent bond joint was insufficient.The root cause of the tubing leak is most likely due to manufacturing operator error during the tube bonding process.Awareness training was completed with manufacturing operators on operation 60a of work instructions to ensure the bond between the clear tubing and spike chamber is sufficient.A quality alert was posted for manufacturing operators as a result of this complaint.Additional corrective actions and/or process improvements may be identified and implemented via capa-2022-0120.No further action is required at this time.Comp-(b)(4).H.M.(b)(6) 2022.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
blanchardstown, dublin, D15 T X2V
EI  D15 TX2V
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin, D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
shelbourne building
53 frontage rd suite 300
hampton, NJ 08827
MDR Report Key15331746
MDR Text Key305372963
Report Number3013428851-2022-00063
Device Sequence Number1
Product Code LNR
Combination Product (y/n)Y
Reporter Country CodeFR
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Nurse
Type of Report Initial,Followup
Report Date 12/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/01/2023
Device Catalogue NumberCLXECP
Device Lot NumberK257
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/04/2022
Initial Date FDA Received08/31/2022
Supplement Dates Manufacturer Received11/10/2022
Supplement Dates FDA Received12/08/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/02/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-